Print page |
E-mail page
| 
Download PDF
|
Add to briefcase
« Previous Release | Next Release »
NEWTON, Mass., Oct 05, 2009 (BUSINESS WIRE) -- Clinical Data, Inc. (NASDAQ: CLDA), today announced that it will host an Investor Day on Thursday, October 8, 2009 beginning at 8:30 a.m. EDT in New York City. The program, "Focus on Vilazodone: A Potential New Treatment for Depression," will feature a series of presentations and panel discussion by leading experts in the treatment of depression, antidepressants and related sexual dysfunction.
Investment professionals interested in attending Clinical Data's investor event should contact Amanda Brown at abrown@clda.comor (617) 527-9933 x3345.
Date: | Thursday, October 8, 2009 | |
Time: | 8:30 a.m. Presentations commence. | |
Webcast: | Available through the Company's website: www.clda.com. Please click on the "Investor Relations" link on the homepage to access events at least five minutes prior to the start of the webcast. | |
Dial-In Information: | ||
| 888-245-0960 or 913-312-1467 (international) | ||
| Passcode 7458158 |
The presentation will be available via webcast and telephonic archive for 30 days beginning two hours after the completion of the live event.
About Clinical Data, Inc.
Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in major therapeutic areas including oncology and inflammatory diseases. Clinical Data plans to differentiate its therapeutics by combining its drug development and biomarker expertise to develop products with enhanced efficacy and tolerability, improving patient health and reducing costs. To learn more, please visit the Company's website at www.clda.com.
SOURCE: Clinical Data, Inc.
Clinical Data, Inc.
Theresa McNeely, 617-527-9933 x3373
Vice President
Corporate Communications
Copyright Business Wire 2009